BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 12469116)

  • 1. TCRs with high affinity for foreign pMHC show self-reactivity.
    Holler PD; Chlewicki LK; Kranz DM
    Nat Immunol; 2003 Jan; 4(1):55-62. PubMed ID: 12469116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-affinity, peptide-specific T cell receptors can be generated by mutations in CDR1, CDR2 or CDR3.
    Chlewicki LK; Holler PD; Monti BC; Clutter MR; Kranz DM
    J Mol Biol; 2005 Feb; 346(1):223-39. PubMed ID: 15663940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structures of high affinity human T-cell receptors bound to peptide major histocompatibility complex reveal native diagonal binding geometry.
    Sami M; Rizkallah PJ; Dunn S; Molloy P; Moysey R; Vuidepot A; Baston E; Todorov P; Li Y; Gao F; Boulter JM; Jakobsen BK
    Protein Eng Des Sel; 2007 Aug; 20(8):397-403. PubMed ID: 17644531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for self-recognition by autoimmune T-cell receptors.
    Yin Y; Li Y; Mariuzza RA
    Immunol Rev; 2012 Nov; 250(1):32-48. PubMed ID: 23046121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CDR3 regions of an immunodominant T cell receptor dictate the 'energetic landscape' of peptide-MHC recognition.
    Borg NA; Ely LK; Beddoe T; Macdonald WA; Reid HH; Clements CS; Purcell AW; Kjer-Nielsen L; Miles JJ; Burrows SR; McCluskey J; Rossjohn J
    Nat Immunol; 2005 Feb; 6(2):171-80. PubMed ID: 15640805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A reliable and safe T cell repertoire based on low-affinity T cell receptors.
    Van Den Berg HA; Rand DA; Burroughs NJ
    J Theor Biol; 2001 Apr; 209(4):465-86. PubMed ID: 11319895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell receptor engineering.
    Stone JD; Chervin AS; Aggen DH; Kranz DM
    Methods Enzymol; 2012; 503():189-222. PubMed ID: 22230570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug interaction with T-cell receptors: T-cell receptor density determines degree of cross-reactivity.
    Depta JP; Altznauer F; Gamerdinger K; Burkhart C; Weltzien HU; Pichler WJ
    J Allergy Clin Immunol; 2004 Mar; 113(3):519-27. PubMed ID: 15007356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extraordinary cross-reactivity of an autoimmune T-cell receptor recognizing specific peptides both on autologous and on allogeneic HLA class II molecules.
    Hansen BE; Rasmussen AH; Jakobsen BK; Ryder LP; Svejgaard A
    Tissue Antigens; 2007 Jul; 70(1):42-52. PubMed ID: 17559580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell allorecognition: a case of mistaken identity or déjà vu?
    Archbold JK; Macdonald WA; Burrows SR; Rossjohn J; McCluskey J
    Trends Immunol; 2008 May; 29(5):220-6. PubMed ID: 18378495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of T cell function by TCR/pMHC binding kinetics.
    Carreño LJ; González PA; Kalergis AM
    Immunobiology; 2006; 211(1-2):47-64. PubMed ID: 16446170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stress-testing the relationship between T cell receptor/peptide-MHC affinity and cross-reactivity using peptide velcro.
    Gee MH; Sibener LV; Birnbaum ME; Jude KM; Yang X; Fernandes RA; Mendoza JL; Glassman CR; Garcia KC
    Proc Natl Acad Sci U S A; 2018 Jul; 115(31):E7369-E7378. PubMed ID: 30021852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell receptors: affinities, cross-reactivities, and a conformer model.
    Holler PD; Kranz DM
    Mol Immunol; 2004 Feb; 40(14-15):1027-31. PubMed ID: 15036906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated TCRs remain marked for internalization after dissociation from pMHC.
    Coombs D; Kalergis AM; Nathenson SG; Wofsy C; Goldstein B
    Nat Immunol; 2002 Oct; 3(10):926-31. PubMed ID: 12244312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfection of drug-specific T-cell receptors into hybridoma cells: tools to monitor drug interaction with T-cell receptors and evaluate cross-reactivity to related compounds.
    Schmid DA; Depta JP; Lüthi M; Pichler WJ
    Mol Pharmacol; 2006 Jul; 70(1):356-65. PubMed ID: 16617162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linking molecular and cellular events in T-cell activation and synapse formation.
    Krogsgaard M; Huppa JB; Purbhoo MA; Davis MM
    Semin Immunol; 2003 Dec; 15(6):307-15. PubMed ID: 15001169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Directed evolution of human T cell receptor CDR2 residues by phage display dramatically enhances affinity for cognate peptide-MHC without increasing apparent cross-reactivity.
    Dunn SM; Rizkallah PJ; Baston E; Mahon T; Cameron B; Moysey R; Gao F; Sami M; Boulter J; Li Y; Jakobsen BK
    Protein Sci; 2006 Apr; 15(4):710-21. PubMed ID: 16600963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient T cell activation requires an optimal dwell-time of interaction between the TCR and the pMHC complex.
    Kalergis AM; Boucheron N; Doucey MA; Palmieri E; Goyarts EC; Vegh Z; Luescher IF; Nathenson SG
    Nat Immunol; 2001 Mar; 2(3):229-34. PubMed ID: 11224522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering improved T cell receptors using an alanine-scan guided T cell display selection system.
    Malecek K; Zhong S; McGary K; Yu C; Huang K; Johnson LA; Rosenberg SA; Krogsgaard M
    J Immunol Methods; 2013 Jun; 392(1-2):1-11. PubMed ID: 23500145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cells behaving badly: structural insights into alloreactivity and autoimmunity.
    Ely LK; Burrows SR; Purcell AW; Rossjohn J; McCluskey J
    Curr Opin Immunol; 2008 Oct; 20(5):575-80. PubMed ID: 18678247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.